Deregulation of the miRNAs Expression in Cervical Cancer: Human Papillomavirus Implications
Table 1
MicroRNAs expression in cervical cancer.
Author
Downregulated
Upregulated
Materials and methods
Reference
Wang et al., 2008
miR-23b, miR-34a, miR-101, miR-143, miR145, miR-218, and miR-424,
miR-15a, miR146a, and miR-223
HPV16+, HPV18+, and HPV negative cervical cancer cell lines; cervical cancer versus age matched normal cervix samples; microarray platform, Northern blot
Let-7b, miR-10b, miR-29a miR-99a, miR-125b, miR-126, miR-218, miR-375, and miR-424
miR-15b, miR-16, miR-17, miR-20a, miR-20b, miR-93, miR-106a, miR-155, and miR-224
Cervical fresh frozen tissues including SCC (), CIN2-3 (), and HR-HPV infected normal cervix with viral cytopathic effect () and disease-free histologically normal specimens (); microarray platform, quantitative RT-PCR
miR-126, miR-143, miR145, miR-195, miR-218, miR-368, and miR-497
miR-182, miR-183, and miR210
HPV16+, HPV18+, and HPV negative cervical cancer lines and cervical cancer tissue samples versus normal cervix samples; microarray platform, Northern blot, quantitative RT-PCR
miR-26a, miR-29a miR-143, miR-145, miR-99a, miR-199a, miR-203, and miR-513
miR-10a, miR-132, miR-148a, miR196a, and miR-302b
Seven cases of high-grade SIL (CINII, , and CIN III, ), 9 cases of low-grade SIL (CIN I), and 19 normal cervix samples; microarray platform, quantitative RT-PCR